BioPharma Credit PLC (LON:BPCP – Get Free Report)’s stock price hit a new 52-week high on Wednesday . The company traded as high as GBX 74 and last traded at GBX 74, with a volume of 71636 shares trading hands. The stock had previously closed at GBX 72.30.
BioPharma Credit Stock Down 1.3%
The stock has a market cap of £980.05 million, a price-to-earnings ratio of 10.54 and a beta of 0.18. The stock’s fifty day moving average is GBX 71.33 and its 200-day moving average is GBX 69.93.
About BioPharma Credit
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.
See Also
- Five stocks we like better than BioPharma Credit
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
